Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Interviews

Interview
Jeffrey Farkas, MD: Ischemic and Hemorrhagic Stroke Intervention
07/22/2019
Jeffrey Farkas, MD, is a neuroradiologist working in an independent practice.
Jeffrey Farkas, MD, is a neuroradiologist working in an independent practice.
Jeffrey Farkas, MD, is a...
07/22/2019
Vascular Disease Management
Cutting-Edge Perspectives
No-Stent Strategy for Femoropopliteal Arterial Disease
07/22/2019
Nicolas Shammas, MD, talks with Ehrin J. Armstrong, MD, Professor of Cardiology, University of Colorado, Aurora, Colorado.
Nicolas Shammas, MD, talks with Ehrin J. Armstrong, MD, Professor of Cardiology, University of Colorado, Aurora, Colorado.
Nicolas Shammas, MD, talks with...
07/22/2019
Vascular Disease Management
Interview
The Management of Tibial Artery Disease in 2019
05/21/2019
Bret N. Wiechmann, MD, discusses current options for treatment, his personal approach to treatment decisions, and upcoming technologies to watch. 
Bret N. Wiechmann, MD, discusses current options for treatment, his personal approach to treatment decisions, and upcoming technologies to watch. 
Bret N. Wiechmann, MD, discusses...
05/21/2019
Vascular Disease Management
Interview
Comparing TCAR to the Traditional Approach for the Treatment of Carotid Artery Stenosis: An Interview With Dr Marc Schermerhorn
12/13/2018
In this interview, Dr. Schermerhorn discusses the results of the TCAR (Trans-Carotid Artery Revascularization) trial, which compared TCAR with CEA in patients with carotid stenosis.
In this interview, Dr. Schermerhorn discusses the results of the TCAR (Trans-Carotid Artery Revascularization) trial, which compared TCAR with CEA in patients with carotid stenosis.
In this interview, Dr....
12/13/2018
Vascular Disease Management
Interview
Geniculate Artery Embolization Offers Pain Relief From Osteoarthritis
08/28/2018
Rachel Piechowiak, DO, discusses the implications of a US clinical trial which investigated the use of geniculate artery embolization for decreasing inflammation and pain in osteoarthritis.
Rachel Piechowiak, DO, discusses the implications of a US clinical trial which investigated the use of geniculate artery embolization for decreasing inflammation and pain in osteoarthritis.
Rachel Piechowiak, DO, discusses...
08/28/2018
Vascular Disease Management
Interview
Registry Data Explores Current Practice of Endovascular Therapy in Korea
08/28/2018
In this Q&A, Donghoon Choi, MD, PhD, comments on data from the Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA) Registry.
In this Q&A, Donghoon Choi, MD, PhD, comments on data from the Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA) Registry.
In this Q&A, Donghoon Choi, MD,...
08/28/2018
Vascular Disease Management
Interview
Freezing the Hunger Nerve: CT-Guided Procedure May Help Patients Lose Weight
07/16/2018
J. David Prologo, MD, the study’s lead author, joined us to discuss the results and what they may mean for patients and the interventional radiologists treating them.
J. David Prologo, MD, the study’s lead author, joined us to discuss the results and what they may mean for patients and the interventional radiologists treating them.
J. David Prologo, MD, the...
07/16/2018
Vascular Disease Management
Intervew
The ATTRACT Trial: Understanding the Results
05/16/2018
The recent publication of the landmark ATTRACT trial has offered important data on the treatment of acute DVT. Anthony Comerota, MD, is one of the authors of the paper, and he joined us to explain the findings of the trial and takeaways for...
The recent publication of the landmark ATTRACT trial has offered important data on the treatment of acute DVT. Anthony Comerota, MD, is one of the authors of the paper, and he joined us to explain the findings of the trial and takeaways for...
The recent publication of the...
05/16/2018
Vascular Disease Management
Interview
A Novel Device to Prevent Neointimal Hyperplasia Restenosis: The DANCE and LIMBO Trials
03/15/2017
VDM spoke with George Adams, MD, MHS, at the 43rd Annual VEITH Symposium regarding the ongoing DANCE and LIMBO trials.
VDM spoke with George Adams, MD, MHS, at the 43rd Annual VEITH Symposium regarding the ongoing DANCE and LIMBO trials.
VDM spoke with George Adams, MD,...
03/15/2017
Vascular Disease Management
Interview
Preliminary Results From the DRASTICO Trial: A Discussion With Francesco Liistro, MD
02/09/2017
An interview with the principal investigator of the ongoing DRASTICO trial, which is comparing drug-eluting stent vs drug-eluting balloon in complex patients.
An interview with the principal investigator of the ongoing DRASTICO trial, which is comparing drug-eluting stent vs drug-eluting balloon in complex patients.
An interview with the principal...
02/09/2017
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement